Many miRNAs are thought to be involved in the development of CVDs, such as miR-20b, which promotes cardiac hypertrophy by targeting the inhibition of mitofusin 2 (MFN2)-mediated intercellular Ca2+ interactions in cardiomyocytes (Qiu et al., 2020). The gene discussed is MFN2; the disease is cardiac hypertrophy.